Skip to main content

Advertisement

ADVERTISEMENT

News

Coloplast

https://investor.coloplast.com/siteassets/corrected-transcript_-coloplast-a_scolo.b-dk-q3-2024-earnings-call-20-august-2024-5_00-am-et.pdf

Coloplast shared that a new RCT comparing the performance of Kerecis fish skin to the standard of care in the treatment of complex DFUs is pending publication. This is the largest Kerecis study to date, with a sample size of more than 250 patients. CLPBF Q3FY24 Earnings Transcript

Advertisement

Advertisement

Advertisement